Generics in transplantation medicine: Randomized comparison of innovator and substitution products containing mycophenolate mofetil .


Journal

International journal of clinical pharmacology and therapeutics
ISSN: 0946-1965
Titre abrégé: Int J Clin Pharmacol Ther
Pays: Germany
ID NLM: 9423309

Informations de publication

Date de publication:
Oct 2019
Historique:
accepted: 20 09 2019
pubmed: 10 8 2019
medline: 1 10 2019
entrez: 10 8 2019
Statut: ppublish

Résumé

Mycophenolate mofetil (MMF) is widely used as an immunosuppressant for the prophylaxis of acute organ rejection in recipients of solid organ transplants. We have compared, in healthy subjects, the pharmacokinetics of mycophenolic acid when MMF was administered in the form of the innovator product CellCept (F. Hoffmann-La Roche Ltd.) or one of three commercially available generics, Renodapt (Biocon Ltd.), Mycept (Panacea Biotec), or Cellmune (Cipla Ltd.). The study was powered to detect a 20% difference in mean formulation performance measures, but not to formally evaluate bioequivalence. Geometric mean ratios of maximum concentrations (C Comparing generics against each other, the differences in point estimates of the geometric mean ratios of C Physicians in the field of transplantation should be aware of the potential risk of altering the therapeutic outcome when switching from one preparation of MMF to another. ClinicalTrials.gov identifier: NCT02981290.

Identifiants

pubmed: 31397274
pii: 185671
doi: 10.5414/CP203487
pmc: PMC6751510
doi:

Substances chimiques

Drugs, Generic 0
Immunosuppressive Agents 0
Mycophenolic Acid HU9DX48N0T

Banques de données

ClinicalTrials.gov
['NCT02981290']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

506-519

Références

Clin J Am Soc Nephrol. 2010 Feb;5(2):341-58
pubmed: 20056756
Clin Pharmacokinet. 2007;46(1):13-58
pubmed: 17201457
Clin Ther. 2003 Nov;25(11):2875-90
pubmed: 14693311
Transpl Int. 2011 Dec;24(12):1135-41
pubmed: 22032583
Int J Clin Pharmacol Ther. 2005 Oct;43(10):485-98
pubmed: 16240706
J Heart Lung Transplant. 2009 Jul;28(7):655-60
pubmed: 19560691
Clin Pharmacokinet. 1998 Jun;34(6):429-55
pubmed: 9646007
Eur J Pharm Sci. 2011 Nov 20;44(4):497-505
pubmed: 21945487
Nephrol Dial Transplant. 2011 Sep;26(9):3019-25
pubmed: 21317409
J Pharm Pharm Sci. 2012;15(1):73-84
pubmed: 22365089
Clin Pharmacol Ther. 1998 Dec;64(6):672-83
pubmed: 9871432
Br J Clin Pharmacol. 2012 Sep;74(3):515-24
pubmed: 22329639
CNS Drugs. 2014 Jan;28(1):69-77
pubmed: 24092569
Ther Drug Monit. 2000 Feb;22(1):20-6
pubmed: 10688252
Ther Drug Monit. 2006 Apr;28(2):145-54
pubmed: 16628123
Appl Health Econ Health Policy. 2010;8(1):61-8
pubmed: 20038194
Am J Law Med. 2012;38(4):667-89
pubmed: 23356099
Eur J Pharm Sci. 2013 Nov 20;50(3-4):476-83
pubmed: 23981332
Am J Kidney Dis. 1999 Feb;33(2):389-97
pubmed: 10023656
Eur J Hosp Pharm. 2013 Oct;20(5):302-307
pubmed: 24089632
Clin Pharmacokinet. 2006;45(2):169-75
pubmed: 16485913
Transplantation. 2007 Feb 27;83(4):417-24
pubmed: 17318074
Epilepsia. 2007 Oct;48(10):1825-32
pubmed: 17850324
Eur J Pharm Sci. 1998 Apr;6(2):87-91
pubmed: 9795020
Transpl Int. 2011 Aug;24(8):770-9
pubmed: 21575080
Transplantation. 1999 Jul 27;68(2):261-6
pubmed: 10440399
Transplantation. 2012 Apr 15;93(7):657-65
pubmed: 22267158
Ther Drug Monit. 2001 Aug;23(4):305-15
pubmed: 11477311
Transplantation. 2015 Nov;99(11):2269-73
pubmed: 26050017
Pharm Res. 2015 Jan;32(1):135-43
pubmed: 25033764
AAPS J. 2012 Dec;14(4):915-24
pubmed: 22972221
Transplant Proc. 2013 Oct;45(8):3035-7
pubmed: 24157030
J Control Release. 1999 Nov 1;62(1-2):33-40
pubmed: 10518632
Transplant Proc. 2014;46(2):415-7
pubmed: 24655977
Int J Clin Pharmacol Ther. 2014 Dec;52(12):1017-22
pubmed: 25295717
Am J Transplant. 2009 Nov;9 Suppl 3:S1-155
pubmed: 19845597
Clin Ther. 2010 Mar;32(3):556-74
pubmed: 20399993
Transpl Int. 2015 May;28(5):508-15
pubmed: 25758949
Ther Deliv. 2013 Jun;4(6):725-40
pubmed: 23738669
Ther Drug Monit. 2014 Apr;36(2):141-7
pubmed: 24081208
Transpl Int. 2012 Jun;25(6):680-6
pubmed: 22500920
Clin Pharmacokinet. 2009;48(11):725-43
pubmed: 19817502
J Pharm Sci. 1993 Nov;82(11):1186-9
pubmed: 7904641
Neurology. 2009 Jun 16;72(24):2122-9
pubmed: 19528520
AAPS J. 2008;10(1):148-56
pubmed: 18446515

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH